InvestorsHub Logo
Followers 32
Posts 2200
Boards Moderated 0
Alias Born 09/01/2020

Re: Turner5 post# 597770

Friday, 06/02/2023 11:51:52 AM

Friday, June 02, 2023 11:51:52 AM

Post# of 705441
Nice, balanced perspective. I mostly agree except revenue uptick post UK approvals will be quite slow if they decide to do it themselves and not go via big pharma through some sort of licensing deal. Reimbursement will be a long hard battle and I don't think they are positioned to maximize the value on their own. Shorts will take advantage of this situation too on any spike we may see on UK approvals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News